US 12,377,135 B2
GHRH antagonists for use in a method of treating sarcoidosis
Mehdi Mirsaeidi, Jacksonville, FL (US); Chongxu Zhang, Riverside, IL (US); Andrew V. Schally, Miami Beach, FL (US); and Renzhi Cai, Miami, FL (US)
Assigned to University of Miami, Miami, FL (US); and The United States Government as Represented by the Department Veterans Affairs, Washington, DC (US)
Filed by University of Miami, Miami, FL (US); and The United States Government as Represented by the Department of Veterans Affairs, Washington, DC (US)
Filed on Jan. 17, 2022, as Appl. No. 17/648,137.
Application 17/648,137 is a continuation of application No. PCT/US2020/042540, filed on Jul. 17, 2020.
Claims priority of provisional application 62/875,703, filed on Jul. 18, 2019.
Prior Publication US 2022/0143149 A1, May 12, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 38/25 (2006.01); A61P 11/00 (2006.01)
CPC A61K 38/25 (2013.01) [A61P 11/00 (2018.01)] 16 Claims
 
1. A method of treating sarcoidosis, the method comprising administering a GHRH antagonist to mammalian subject in need thereof.